Abstract
Ovarian hyperstimulation syndrome is a severe and potentially fatal iatrogenic disease that affects 2% of women subjected to pharmacological induction of ovulation. The newest data on the clinical picture, risk factors, pathophysiology and management of this disease, are reviewed.
MeSH terms
-
Female
-
Humans
-
Intensive Care Units
-
Ovarian Hyperstimulation Syndrome / diagnostic imaging
-
Ovarian Hyperstimulation Syndrome / physiopathology
-
Ovarian Hyperstimulation Syndrome / therapy*
-
Ovulation Induction / adverse effects
-
Risk Factors
-
Severity of Illness Index
-
Ultrasonography